Roussel, M., Ferrant, J., Manbangui, I. C., Gallou, S. L., BROTTIER, C., Rossille, D., DULONG, J., Delfau, M., Claudel, A., Lemonnier, F., Houot, R., Laurent, C., Tarte, K. (2025). Circulating CD161high CD8 T cells at leukapheresis are associated with reduced risk of progression at 12 months (PFS12) in large B-cell lymphoma treated by axicabtagene ciloleucel: Results from the Phase 2 alycante study (LYSA). Blood. https://doi.org/10.1182/blood-2025-5332